The activated clotting time (ACT) may be an unreliable monitor of coagulation for patients with the antiphospholipid syndrome. We describe a patient with antiphospholipid syndrome in whom adequate anticoagulation during cardiopulmonary bypass was confirmed by monitoring both the ACT and anti-factor Xa levels. The cardiopulmonary bypass was uneventful, and there were no thrombotic or bleeding complications. The use of anti-factor Xa levels provided confirmation of adequate anticoagulation (and reversal of anticoagulation) that was not possible using the ACT alone.
CioccaR.G., ChoiJ., GrahamA.M.Antiphospholipid antibodies lead to increased risk in cardiovascular surgery.Am J Surg1995; 170: 198–200.
3.
SantoroS.A.Antiphospholipid antibodies and thrombotic predisposition: underlying pathogenic mechanism.Blood1994; 83: 2389–2391.
4.
MetzdorffM., HansesK.S., WrightG.L., FriedS.J.Interference with anticoagulation monitoring by procainamide induced lupus anticoagulant.Ann Thorac Surg1996; 61: 994–995.
5.
LoveP.E., SantoroS.A.Antiphospholipid antibodies: anticardiolipin and the lupus anticoagulant in systemic lupus erythematosis (SLE) and in non-SLE disorders.Ann Int Med1990; 12: 682–698.
6.
MooreR.A.Monitoring hemostasis. In LakeCl, ed. Clinical Monitoring for Anesthesia and Critical Care, 2nd Ed.WB Saunders, Philadelphia1994; 490–517.
7.
SheikhF., LechowiczA., SetlurR., RauchA., DunnH.Recognition and management of patients with antiphospho-lipid antibody syndrome undergoing cardiac surgery.J Cardiothor Vasc Anesth1997; 11: 764–766.
8.
DucartA.R., CollardE.L., OsselaerJ.C.Management of anticoagulation during cardiopulmonary bypass in a patient with a circulating lupus anticoagulant.J Cardiothor Vasc Anesth1997; 11: 878–879.
9.
KellyJ.P., LeonardT., MoulderP.V., WebbW.R.Coronary bypass surgery in patients with circulating lupus anticoagulant.Ann Thorac Surg1985; 40: 261–263.
10.
MyersG., HirschG.M.Double valve replacement in a patient with anticardiolipin antibody syndrome.Perfusion1999; 14: 397–401.
11.
HoganW.J., McBaneR.D., SantrachP.J.Antiphospholipid syndrome and perioperative hemostatic management of cardiac valvular surgery.Mayo Clin Proc2000; 75: 971–976.
12.
EastC.J., ClementsF., MathewJ., SlaughterT.F.Antiphospholipid syndrome and cardiac surgery: management of anticoagulation in two patients.Anesth Analg2000; 90: 1098–1101.
13.
OlsonJ.D., ArkinC.F., BrandtJ.T.College of American Pathologists Conference XXXI on laboratory monitoring of anticoagulant therapy: laboratory monitoring of unfractionated heparin therapy.Arch Pathol Lab Med1998; 122: 782–798.
14.
GalliM., FinazziG., BeversE.M., BarbuiT.Kaolin clotting time and dilute Russell's viper venom time distinguish between prothrombin-dependent and beta 2-glycoprotein I-dependent antiphospholipid antibodies.Blood1995; 86: 617–623.
